| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.35 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |